Show Stocks and Investing Publications • Tue, August 8, 2023
Keay Nakae Reiterated (ALNY) at Strong Buy and Held Target at $250 on, Aug 8th, 2023
ae-reiterated-alny-at-strong-buy-and-held-target-at-250-on-aug-8th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIKeay Nakae of Chardan Capital, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $250 on, Aug 8th, 2023.
Keay has made no other calls on ALNY in the last 4 months.
There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 3 agree with Keay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $200 on, Thursday, July 13th, 2023
- David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
These are the ratings of the 5 analyists that currently disagree with Keay
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, August 7th, 2023
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, August 4th, 2023
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Friday, August 4th, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
Like: 👍